期刊文献+

替吉奥胶囊治疗老年晚期胃癌的临床疗效观察 被引量:23

Clinical Observation of S1 Capsule in the Treatment of Elderly Patients with Advanced Gastric Cancer
下载PDF
导出
摘要 目的探讨口服替吉奥胶囊治疗老年晚期胃癌的近期疗效及不良反应。方法 30例老年晚期胃癌患者随机分为2组,观察组15例,予替吉奥胶囊口服,连服14天,停7天;对照组15例,采用FOLFOX4方案化疗,每2周重复一次。治疗3个周期后2组进行疗效评估。结果观察组有效率为40.0%,对照组有效率为33.3%,2组差异无统计学意义(P>0.05)。观察组不良反应发生率较对照组低,有统计学意义(P<0.05)。结论替吉奥胶囊治疗老年晚期胃癌疗效肯定,不良反应轻,患者耐受性好。 Objective To explore the short-term efficacy and side effects of S1 capsule in the treatment of elderly pa- tients with advanced gastric cancer. Methods 30 elderly patients with advanced gastric cancer were randomly divided into two groups, including 15 cases of observation group, 15 cases of control group. The observation group was given S1 capsule orally for 14 days and out of service for 7 days. The control group was given FOLFOX4 regimen every two weeks in a circle. Efficacy in treatment group and control group were evaluated after 3 circles. Results In observation group, the effective rate was 40.0% , and in control group, the effective rate was 33.3%, the difference was not statistically significant (P 〉 0. 05 ). The side effects in ob- servation group were significantly lower than that of control group ( P 〈 0.05 ). Conclusion S1 capsule is an effective treatment for elderly patients with advanced gastric cancer,and it has mild side effects and better toleration.
出处 《实用癌症杂志》 2013年第2期163-165,共3页 The Practical Journal of Cancer
关键词 替吉奥 晚期胃癌 化疗 S1 capsule Advanced gastric cancer Chemotherapy
  • 相关文献

参考文献18

二级参考文献26

  • 1钱军,秦叔逵,梅静峰,陈映霞,邵志坚,何泽明.奥沙利铂联合卡培他滨二线治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2004,26(12):746-748. 被引量:60
  • 2Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74. 被引量:1
  • 3Miller A B,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47(1):207. 被引量:1
  • 4Alberts SR,Cervantes A,VANDE Velde CJ,et al.Gastric cancer:epidemiology,pathology and treatment[J].Ann Oncol,2003,14(suppl 2):S31. 被引量:1
  • 5Sato A,Ito T,Tomita T.Chemotherapy of gastric cancer-a review of clinical trials in Japan 2002[J].Gan To Kaggku Ryobo,2002,29(9):1522. 被引量:1
  • 6Koizumi W.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer.(SPIRITS trial):a phase Ⅲ trial[J].Lancet Oncol,2008,9(3):215. 被引量:1
  • 7Boku N.Chemotherapy for metastatic disease:review from JCOG trials[J].International Journal of Clinical Oncology,2008,13(3):196. 被引量:1
  • 8白坂哲彦 佃守犬山 夫他新规.经口抗癌剂TS-1(S-1).癌症化学疗法,2001,:855-864. 被引量:9
  • 9Moiseyenko VM,Ajani JA,Tjulandin SA,et al.Final results of a randomized controlled phase Ⅲ trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F)to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)[ J ].J Clin Onc,Proc Am Soc Clin Oncol,2005,23:Abstract 4002. 被引量:1
  • 10Al-Batran S,Hartmann J,Probst S,et al.A randomized phase Ⅲ trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil,leucovorin and oxaliplatin (FLO) versus fluorouracil,leucovorin and cisplatin (FLP)[J].J Clin Onc,Proc Am Soc Clin Oncol,2006,24:Abstract 4016. 被引量:1

共引文献405

同被引文献175

引证文献23

二级引证文献135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部